Dylan Reid

Partner at Zetta

New York, New York

Overview

Dylan Reid is a Partner at Zetta Venture Partners in New York, with a focus on investing in various sectors and stages, including Consumer Health, BioTech, and AI. He has made significant investments in companies like Noetik, Nanite, Nabla Bio, and Fox Robotics. Reid's career highlights include actively participating in fundraising, management, and policy research, as well as demonstrating strong leadership skills in the venture capital and entrepreneurship space.

Work Experience

Zetta Venture Partners

Managing Director
2025 - Current
Partner
2018 - 2025

Axiom Bio

Investor / Advisor
2024
Building multi-modal models of toxicology to close the "translational gap" in AI drug development.

Nabla Bio, Inc.

Investor / Observer
2021
Using Protein Language Models and Massively Multiplex Screening to Design Impossible Antibodies.

Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.

Raised $37,381,000.00 from Fifty Years, Khosla Ventures, Zetta Venture Partners, Radical Ventures, Y Combinator, Boom Capital Ventures and Cantos.

nabla.bio

NOETIK

Investor / Observer
2022
Using Foundation Models and Spatial Biology to Discover Targeted Immunotherapies.

Faro Health Inc.

Investor / Director
2019
Using LLMs to Design Better, Faster, More Efficient Clinical Trials.

Faro Health is a company that handles the tedious work better left for a computer.

Raised $35,000,000.00 from General Catalyst, Polaris Partners, Section 32, Northpond Ventures, Zetta Venture Partners, Section 32, Polaris Partners, Northpond Ventures and Zetta Venture Partners.

farohealth.com